Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Most-Read News CME Articles — February 2008: New AHA/ACC Performance Measures for AF
Link ID 3650
Title Most-Read News CME Articles — February 2008: New AHA/ACC Performance Measures for AF
Url http://www.medscape.com/viewarticle/570876?src=rss
Description The most popular News CME stories in February have examined the new performance measures for atrial fibrillation; new guidelines for managing asthma during pregnancy; and more. Medscape Medical News
Category Articles > Allergy and Clinical Immunology
Keywords
Date Mar 1, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Allergy and Clinical Immunology
1. Gene Variant Increases Risk of Asthma
  A variant in CHI3L1, the gene that encodes the chitinase-like protein YKL-40, is associated with asthma, bronchial hyperresponsiveness, and reduced lung function, new study findings show. Reuters Health Information
Category:   Articles > Allergy and Clinical Immunology


2. HIV Immunopathogenesis and Correlates of Protection
  Dr. Michael M. Lederman highlights the presentations from CROI 2008 regarding the immune response to HIV Infection. Medscape HIV/AIDS
Category:   Articles > Allergy and Clinical Immunology


3. Aspirin Desensitization Therapy Can Be Cost Effective
  Aspirin desensitization is a cost-effective measure when used in patients with moderate-to-severe aspirin-exacerbated respiratory disease (AERD). However, when required for antiplatelet therapy, clopidogrel is not a prohibitively expensive option. Reuters Health Information
Category:   Articles > Allergy and Clinical Immunology


4. Pharmacovigilance in Nephrology
  Recent controversies about heparin contamination from China and ESA adverse effects raise questions about drug safety and FDA oversight.
Medscape Nephrology
Category:   Articles > Allergy and Clinical Immunology


5. FDA Safety Changes: Celebrex, Kaletra, Zestril, Zestoretic
  The FDA has approved revisions to the safety labeling for celecoxib capsules, lopinavir/ritonavir tablets and oral solution, lisinopril tablets, and lisinopril/hydrochlorothiazide tablets. Medscape Medical News
Category:   Articles > Allergy and Clinical Immunology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS